Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: arrhythmia
Total 0 results
Nothing found
Sponsors and Collaborators
Alkay Kara
Navitor Pharmaceuticals, Inc.
Conavi
ThermaSENSE Corp
Peschke GmbH
Centre for clinical studies, Bergen, Norway
St Thomas
Shanxi Traditional Chinese Medicine Hospital
Invicro, Boston
Shanghai WD Pharmaceutical Co., Ltd.
Highland Instruments, Inc.
Ministerio de Salud y Protección Social, Colombia
Orlando Immunology Clinic, Orlando FL
University Clinic Essen
Ecole des Mines Saint-Etienne
Nankai University School of Medicine
Kwandong University Myongji Hospital
Hamilton Health Sciences Center
Weifeng Tu
Dina Mohamed Refaat Dakhly
View Full List
Medical Conditions
Stage III Vaginal Cancer AJCC v6 and v7
Antifungal Prophylaxis of Invasive Fungal Infections
Trichomonas
Apnea of Newborn
Stage IIIB Bladder Cancer AJCC v8
Taeniosis
Neck
CORE Condition
Digital Education Interventions
Prostate Cancer After a Radical Treatment
Brown-Sequard Syndrome
Gestational Age Conditions
Improved VO2max and Cardiac Output in Response to Training
Medium Flow Anesthesia
High Grade Lymphomas
SCLC, Extensive Stage
Unresectable Mucosal Melanoma
Glutamine Levels
Patients With Migraine Equal of /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months Preceding the Screening
Disorder of Pregnancy
View Full List
Drug Interventions
BIIL 284 BS tablet D
Cyclophosphamide
Carboplatin
Once weekly subcutaneous injection of TransCon hGH
Amitriptyline
Lurasidone 80 mg once daily initially rerandomized either to 80 mg or 160 mg at week 2
Dysport
ATG+mycophénolate mofétil+tacrolimus
Etoposide
Mosunetuzumab + Lenalidomide
Candesartan Cilexetil
Verteporfin
Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin
MK-0634 50 mg
Hydroxyethylstarch 130/0.4
NRC-2694-A
THOR-707
SPC1001 Low
5-fluorouracil
UH-AC 62 XX tablet
View Full List
CROs by country
Contract Research Organizations in Benin
Contract Research Organizations in Cambodia
Contract Research Organizations in Canada
Contract Research Organizations in Chile
Contract Research Organizations in Czech Republic
Contract Research Organizations in Ecuador
Contract Research Organizations in Egypt
Contract Research Organizations in Japan
Contract Research Organizations in Malta
Contract Research Organizations in Moldova
Contract Research Organizations in Montenegro
Contract Research Organizations in South Africa
Contract Research Organizations in Togo
CRO list by country
CROs in Oman
SGS
All CROs in Oman
3
X